Peixiang Lan

1.8k total citations · 2 hit papers
34 papers, 1.2k citations indexed

About

Peixiang Lan is a scholar working on Immunology, Molecular Biology and Oncology. According to data from OpenAlex, Peixiang Lan has authored 34 papers receiving a total of 1.2k indexed citations (citations by other indexed papers that have themselves been cited), including 23 papers in Immunology, 12 papers in Molecular Biology and 11 papers in Oncology. Recurrent topics in Peixiang Lan's work include Immune Cell Function and Interaction (9 papers), Immunotherapy and Immune Responses (9 papers) and Immune cells in cancer (5 papers). Peixiang Lan is often cited by papers focused on Immune Cell Function and Interaction (9 papers), Immunotherapy and Immune Responses (9 papers) and Immune cells in cancer (5 papers). Peixiang Lan collaborates with scholars based in China, United States and Saudi Arabia. Peixiang Lan's co-authors include Zhigang Tian, Cai Zhang, Qiuju Han, Li X, Xiang Xiao, Qingwen Li, Jian Zhang, Xin Yu, Yihui Fan and Xuben Hou and has published in prestigious journals such as Proceedings of the National Academy of Sciences, Journal of Clinical Investigation and Nature Communications.

In The Last Decade

Peixiang Lan

29 papers receiving 1.2k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Activation of immune signals during organ transplantation

2023 75 citations Qingwen Li, Peixiang Lan profile →
Histone lactylation-driven B7-H3 expression promotes tumor immune evasion

2025 26 citations Wenlong Jia, Peixiang Lan et al. Theranostics profile →

Peers

Countries citing papers authored by Peixiang Lan

Since Specialization

Citations

This map shows the geographic impact of Peixiang Lan's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Peixiang Lan with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Peixiang Lan more than expected).

Fields of papers citing papers by Peixiang Lan

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Peixiang Lan. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Peixiang Lan. The network helps show where Peixiang Lan may publish in the future.

Co-authorship network of co-authors of Peixiang Lan

This figure shows the co-authorship network connecting the top 25 collaborators of Peixiang Lan. A scholar is included among the top collaborators of Peixiang Lan based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Peixiang Lan. Peixiang Lan is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	Setdb1 ablation in macrophages attenuates fibrosis in heart allografts 2025 ·Proceedings of the National Academy of Sciences ·(unknown), Xi Zhou, Wenjun Jia, Xiaosheng Tan, (unknown), (unknown), (unknown), (unknown), (unknown), Ningyi Yuan, Ping Liu, (unknown), Zhishui Chen, Peixiang Lan	0
2	High mobility group box-1 protein–mediated class II major histocompatibility complex transactivator superenhancers are critical for dendritic cell–trained immunity in acute-to-chronic progression of allograft rejection 2025 ·American Journal of Transplantation ·(unknown), (unknown), Xiaosheng Tan, (unknown), (unknown), (unknown), Peixiang Lan, Song Chen, Gang Chen	2
3	Targeting Setdb1 in T cells induces transplant tolerance without compromising antitumor immunity 2025 ·Nature Communications ·Xiaosheng Tan, (unknown), Zunsong Hu, Ding‐Sheng Jiang, (unknown), (unknown), (unknown), (unknown), Bin Xie, (unknown), Min Ma, Cong‐Yi Wang, Shu Zhang, Li Chen, Zhishui Chen, Gang Chen, Peixiang Lan	2
4	Decoding the peripheral neuro-immune Axis: A new frontier in disease therapy 2025 ·Neurobiology of Disease ·Ningyi Yuan, Yanping Lin, Zhibo Ma, (unknown), Qingwen Li, Peixiang Lan, (unknown)	0
5	IRF4 expression by NK precursors predetermines exhaustion of NK cells during tumor metastasis 2025 ·Nature Immunology ·(unknown), Zheng Yin, Jie Wu, Xiang Xiao, Dawei Zou, (unknown), Jinfei Fu, Peixiang Lan, Laurie J. Minze, Li X, Wenhao Chen	1
6	A prognostic model based on CLEC6A predicts clinical outcome of breast cancer patients 2024 ·International Immunopharmacology ·(unknown), (unknown), Qiang Liu, (unknown), Xingrui Li, Shu Peng, Peixiang Lan, (unknown)	1
7	CBX4 suppresses CD8⁺ T cell antitumor immunity by reprogramming glycolytic metabolism 2024 ·Theranostics ·(unknown), Wenlong Jia, Xi Kathy Zhou, Zhibo Ma, Jing Liu, Peixiang Lan	6
8	USP25 stabilizes STAT6 to promote IL-4-induced macrophage M2 polarization and fibrosis 2024 ·International Journal of Biological Sciences ·Yu Xu, Jing Liu, (unknown), (unknown), Peixiang Lan, (unknown)	5
9	LRP11 promotes stem-like T cells via MAPK13-mediated TCF1 phosphorylation, enhancing anti-PD1 immunotherapy 2024 ·Journal for ImmunoTherapy of Cancer ·(unknown), Zhibo Ma, (unknown), Xiaosheng Tan, (unknown), (unknown), Li Chen, Zhishui Chen, Gang Chen, Peixiang Lan	4
10	Gut microbiota-mediated bile acid metabolism aggravates biliary injury after liver transplantation through mitochondrial apoptosis 2024 ·International Immunopharmacology ·Lu Wang, (unknown), Yuanyuan Zhao, Bo Yang, Guobin Huang, Junbo Li, Xi Zhou, Hongmei Jiang, Peixiang Lan, Zhishui Chen	2
11	The Role of Immune Cells in the Pathogenesis of Idiopathic Pulmonary Fibrosis 2023 ·Medicina ·(unknown), Peixiang Lan, Tao Wang	25
12	Guidance of super-enhancers in regulation of IL-9 induction and airway inflammation 2018 ·The Journal of Experimental Medicine ·Xiang Xiao, Yihui Fan, Junhui Li, Xiaolong Zhang, X. Lou, Yaling Dou, Xiaomin Shi, Peixiang Lan, Yue Xiao, Laurie J. Minze, Li X	58
13	OX40 Costimulation Inhibits Foxp3 Expression and Treg Induction via BATF3-Dependent and Independent Mechanisms 2018 ·Cell Reports ·Xiaolong Zhang, Xiang Xiao, Peixiang Lan, Junhui Li, Yaling Dou, Wenhao Chen, Naoto Ishii, Shuqiu Chen, Bo Xia, Kaifu Chen, Elizabeth J. Taparowsky, Li X	95
14	Macrophage subpopulations and their impact on chronic allograft rejection versus graft acceptance in a mouse heart transplant model 2017 ·American Journal of Transplantation ·Yue Zhao, Song Chen, Peixiang Lan, Chenglin Wu, Yaling Dou, Xiang Xiao, Zhiqiang Zhang, Laurie J. Minze, Xiaoshun He, Wenhao Chen, Li X	58
15	TNF superfamily receptor OX40 triggers invariant NKT cell pyroptosis and liver injury 2017 ·Journal of Clinical Investigation ·Peixiang Lan, Yihui Fan, Yue Zhao, X. Lou, Howard Monsour, Xiaolong Zhang, Yongwon Choi, Yaling Dou, Naoto Ishii, Rafik M. Ghobrial, Xiang Xiao, Li X	53
16	The Costimulatory Receptor OX40 Inhibits Interleukin-17 Expression through Activation of Repressive Chromatin Remodeling Pathways 2016 ·Immunity ·Xiang Xiao, Xiaomin Shi, Yihui Fan, Chenglin Wu, Xiaolong Zhang, Laurie J. Minze, Wentao Liu, Rafik M. Ghobrial, Peixiang Lan, Li X	59
17	HBV inhibits LPS-induced NLRP3 inflammasome activation and IL-1β production via suppressing the NF-κB pathway and ROS production 2016 ·Journal of Hepatology ·Xin Yu, Peixiang Lan, Xuben Hou, Qiuju Han, Nan Lü, Tao Li, (unknown), Jian Zhang, Cai Zhang, Zhigang Tian	287
18	Graft-Infiltrating Macrophages Adopt an M2 Phenotype and Are Inhibited by Purinergic Receptor P2X7 Antagonist in Chronic Rejection 2016 ·American Journal of Transplantation ·Chenglin Wu, Yue Zhao, Xiang Xiao, Yihui Fan, M. Kloc, (unknown), R. Mark Ghobrial, Peixiang Lan, Xin He, Li X	56
19	Table of Contents 2015 ·Australian Journal of Chemistry ·(unknown), Antony L. Crisp, Jinshuo Li, Peixiang Lan, (unknown), (unknown), Martin G. Banwell, Jeffrey R. Reimers, (unknown), Anthony P. O’Mullane, (unknown), Jason A. Smith, Christopher S. P. McErlean, (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown)	1
20	Immunotherapy for Hepatoma Using a Dual-Function Vector with Both Immunostimulatory and Pim-3–Silencing Effects 2014 ·Molecular Cancer Therapeutics ·Qie Guo, Peixiang Lan, Xin Yu, Qiuju Han, Jian Zhang, Zhigang Tian, Cai Zhang	26

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact